Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort

R. Ghosal; K. E. Lewis; P. Kloer; S. Bayliss; Luis Alejandro Jose Mur; P. D. Lewis

doi:10.1136/thx.2010.150912.38

Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort

R. Ghosal
, K. E. Lewis
, P. Kloer
, S. Bayliss
, Luis Alejandro Jose Mur
, P. D. Lewis

Institute of Biological, Environmental, and Rural Sciences

Research output: Chapter in Book/Report/Conference proceeding › Conference Proceeding (ISBN)

Abstract

New cheap and high throughput technologies may allow earlier diagnosis and cost-effective screening programmes for lung cancer (LC). We have shown that sputum is a feasible biofluid for FTIR spectroscopy analysis1 and now further evaluate FTIR in diagnosing LC.

Original language	English
Title of host publication	British Thoracic Society Winter Meeting 2010
Pages	A19-A20
DOIs	https://doi.org/10.1136/thx.2010.150912.38
Publication status	Published - 2010
Event	British Thoracic Society Winter Meeting 2010 - London, United Kingdom of Great Britain and Northern Ireland Duration: 01 Jan 2010 → 03 Jan 2010

Conference

Conference	British Thoracic Society Winter Meeting 2010
Country/Territory	United Kingdom of Great Britain and Northern Ireland
City	London
Period	01 Jan 2010 → 03 Jan 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1136/thx.2010.150912.38

http://hdl.handle.net/2160/7006

Permanent link

Persistent link

Cite this

@inproceedings{cc9a6f1a7695457584dfe98cc25dd394,

title = "Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort",

abstract = "New cheap and high throughput technologies may allow earlier diagnosis and cost-effective screening programmes for lung cancer (LC). We have shown that sputum is a feasible biofluid for FTIR spectroscopy analysis1 and now further evaluate FTIR in diagnosing LC.",

author = "R. Ghosal and Lewis, \{K. E.\} and P. Kloer and S. Bayliss and Mur, \{Luis Alejandro Jose\} and Lewis, \{P. D.\}",

note = "Ghosal, R., Lewis, K.E., Kloer, P., Bayliss, S., Mur, L.A.J., Lewis, P.D. (2010). Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort. Thorax, 65, (suppl. 4), A19-A20.; British Thoracic Society Winter Meeting 2010 ; Conference date: 01-01-2010 Through 03-01-2010",

year = "2010",

doi = "10.1136/thx.2010.150912.38",

language = "English",

pages = "A19--A20",

booktitle = "British Thoracic Society Winter Meeting 2010",

}

Ghosal, R, Lewis, KE, Kloer, P, Bayliss, S, Mur, LAJ & Lewis, PD 2010, Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort. in British Thoracic Society Winter Meeting 2010. pp. A19-A20, British Thoracic Society Winter Meeting 2010, London, United Kingdom of Great Britain and Northern Ireland, 01 Jan 2010. https://doi.org/10.1136/thx.2010.150912.38

TY - GEN

T1 - Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort

AU - Ghosal, R.

AU - Lewis, K. E.

AU - Kloer, P.

AU - Bayliss, S.

AU - Mur, Luis Alejandro Jose

AU - Lewis, P. D.

N1 - Ghosal, R., Lewis, K.E., Kloer, P., Bayliss, S., Mur, L.A.J., Lewis, P.D. (2010). Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort. Thorax, 65, (suppl. 4), A19-A20.

PY - 2010

Y1 - 2010

N2 - New cheap and high throughput technologies may allow earlier diagnosis and cost-effective screening programmes for lung cancer (LC). We have shown that sputum is a feasible biofluid for FTIR spectroscopy analysis1 and now further evaluate FTIR in diagnosing LC.

AB - New cheap and high throughput technologies may allow earlier diagnosis and cost-effective screening programmes for lung cancer (LC). We have shown that sputum is a feasible biofluid for FTIR spectroscopy analysis1 and now further evaluate FTIR in diagnosing LC.

U2 - 10.1136/thx.2010.150912.38

DO - 10.1136/thx.2010.150912.38

M3 - Conference Proceeding (ISBN)

SP - A19-A20

BT - British Thoracic Society Winter Meeting 2010

T2 - British Thoracic Society Winter Meeting 2010

Y2 - 1 January 2010 through 3 January 2010

ER -

Fourier transform infra-red (FTIR) spectroscopy on sputum from lung cancer patients, healthy controls and a high-risk cohort

Abstract

Conference

UN SDGs

Access to Document

Permanent link

Fingerprint

Cite this